Spero Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2016 | — | — | $-5.9M |
| Jun 2016 | — | — | $-6.1M |
| Sep 2016 | — | $-7.9M | $-6.3M |
| Dec 2016 | — | — | $-7.2M |
| Mar 2017 | $140.0K | $-7.6M | $-5.9M |
| Jun 2017 | $249.0K | $-10.2M | $-9.2M |
| Sep 2017 | $597.0K | $-10.0M | $-9.8M |
| Dec 2017 | $993.0K | — | $-13.9M |
| Mar 2018 | $1.2M | $-10.8M | $-10.6M |
| Jun 2018 | $463.0K | $-10.0M | $-10.0M |
| Sep 2018 | $658.0K | $-10.9M | $-10.5M |
| Dec 2018 | $1.7M | — | $-10.6M |
| Mar 2019 | $7.7M | $-5.7M | $-5.1M |
| Jun 2019 | $2.2M | $-13.7M | $-13.2M |
| Sep 2019 | $4.6M | $-18.0M | $-17.7M |
| Dec 2019 | $696.0K | — | $-25.0M |
| Mar 2020 | $1.7M | $-22.8M | $-23.3M |
| Jun 2020 | $1.7M | $-18.5M | $-17.5M |
| Sep 2020 | $4.0M | $-19.0M | $-18.9M |
| Mar 2021 | $7.3M | $-19.4M | $-19.4M |
| Jun 2021 | $5.1M | $-18.5M | $-18.6M |
| Sep 2021 | $3.1M | $-22.5M | $-22.5M |
| Mar 2022 | $2.1M | $-30.2M | $-32.8M |
| Jun 2022 | $2.0M | $-26.1M | $-28.7M |
| Sep 2022 | $2.0M | $-11.8M | $-11.7M |
| Mar 2023 | $2.1M | $-14.2M | $-13.3M |
| Jun 2023 | $2.7M | $-12.9M | $-11.9M |
| Sep 2023 | $25.5M | $-1.9M | $-3.2M |
| Mar 2024 | $9.3M | $-14.0M | $-12.7M |
| Jun 2024 | $10.2M | $-19.1M | $-17.9M |
| Sep 2024 | $13.5M | $-18.6M | $-17.1M |
| Mar 2025 | $5.9M | $-14.7M | $-13.9M |
| Jun 2025 | $14.2M | $-2.4M | $-1.7M |
| Sep 2025 | $5.4M | $-7.9M | $-7.4M |
| Mar 2026 | $258.0K | $-7.5M | $-7.2M |
| Jun 2026 | $0 | $-9.9M | $-9.6M |